Journal of Vascular Surgery
Volume 51, Issue 3 , Pages 707-711, March 2010

A portable high-intensity focused ultrasound device for noninvasive venous ablation

  • Peter W. Henderson, MD

      Affiliations

    • Laboratory for Bioregenerative Medicine and Surgery, Department of Surgery, Weill Cornell Medical College, New York, NY
  • ,
  • George K. Lewis, BS

      Affiliations

    • Department of Biomedical Engineering, Cornell University, Ithaca , NY
  • ,
  • Naima Shaikh, BA

      Affiliations

    • Laboratory for Bioregenerative Medicine and Surgery, Department of Surgery, Weill Cornell Medical College, New York, NY
  • ,
  • Allie Sohn, BA

      Affiliations

    • Laboratory for Bioregenerative Medicine and Surgery, Department of Surgery, Weill Cornell Medical College, New York, NY
  • ,
  • Andrew L. Weinstein, BS

      Affiliations

    • Laboratory for Bioregenerative Medicine and Surgery, Department of Surgery, Weill Cornell Medical College, New York, NY
  • ,
  • William L. Olbricht, PhD

      Affiliations

    • Department of Biomedical Engineering, Cornell University, Ithaca , NY
  • ,
  • Jason A. Spector, MD, FACS

      Affiliations

    • Laboratory for Bioregenerative Medicine and Surgery, Department of Surgery, Weill Cornell Medical College, New York, NY
    • Corresponding Author InformationCorrespondence: Jason A. Spector, MD, FACS, 525 E. 68th St, Payson 709-A New York, NY 10065
    web address

Received 18 July 2009; accepted 4 October 2009. published online 04 January 2010.

Background

Varicose veins and other vascular abnormalities are common clinical entities. Treatment options include vein stripping, sclerotherapy, and endovenous laser treatment, but all involve some degree of invasive intervention. The purpose of this study was to determine ex vivo the effectiveness of a novel hand-held, battery-operated, high-intensity focused ultrasound (HIFU) device for transcutaneous venous ablation.

Methods

The ultrasound device is 14 × 9 × 4 cm, weighs 650 g, and is powered by 4 lithium ion battery packs. An ex vivo testing platform consisting of two different models comprised of sequentially layered skin-muscle-vein or skin-fat-vein was developed, and specimens were treated with HIFU. The tissues were then disassembled, imaged, and processed for histology. The luminal cross-sectional area of vein that had been treated with HIFU and nontreated controls were measured, and the values presented as median and interquartile range (IQR). The values were compared using a Wilcoxon rank-sum test, and statistical significance was set at P < .05.

Results

On gross and histologic examination, veins that had been treated with HIFU showed evidence of coagulation necrosis. The surface of the muscle in direct contact with the vein had a pinpoint area of coagulation, whereas the adjacent fat appeared undisturbed; the skin, fat, and the surface of the muscle in contact with the transducer remained completely unaffected. The cross-sectional area was 3.79 mm2 (IQR, 3.38-4.22) of the control vein lumen and 0.16 mm2 (IQR, 0.04-0.39) in those that had been treated with HIFU (P = .0304).

Conclusion

This inexpensive, portable HIFU device has the potential to allow clinicians to easily perform venous ablation in a manner that is entirely noninvasive and without the expense or inconvenience of large, complicated devices. This device represents a significant step forward in the development of new applications for HIFU technology.

Clinical Relevance

Although sclerotherapy, radiofrequency ablation, and endovenous laser treatment are less invasive than previous surgical treatments for varicose veins, they are still invasive procedures and have concomitant risks, complications, and expenses. The development of a transcutaneous, noninvasive treatment modality holds significant promise for the treatment of varicose veins and venous malformations.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Competition of interest: none.

 Funding for this project was obtained in part from a grant from the Empire Clinical Research Investigator Program (New York).

 The editors and reviewers of this article have no relevant financial relationships to disclose per the JVS policy that requires reviewers to decline review of any manuscript for which they may have a competition of interest.

PII: S0741-5214(09)02103-X

doi:10.1016/j.jvs.2009.10.049

Journal of Vascular Surgery
Volume 51, Issue 3 , Pages 707-711, March 2010